Ifosfamine and etoposide in 26 cases with relapse ovarian carcinoma / 中国癌症杂志
China Oncology
;
(12)2000.
Article
Dans Chinois
| WPRIM
| ID: wpr-674737
ABSTRACT
Purpose:
To investigate the treatment effect and toxicity of regimen containing ifosfamide (IFO) and etoposide (VP16) on relapse ovarian carcinoma.Methods:
IFO 2.0 in 500 ml normal saline day 1—5, VP16 100 mg in 500 ml normal saline d1,3,5Results:
The overall response rate was 38.5%, mylosuppression and alopecia were the most common toxicities. Leukopenia rate was 71.4%, alopecia rate was 100%, gastro intestinal and nervous toxicity were mild.Conclusions:
Combination of IFO and VP16 was very effective on relapse ovarian carcinoma with mild toxicity and should be widely used.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
langue:
Chinois
Texte intégral:
China Oncology
Année:
2000
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS